Glucagon-Like Peptide-1 Receptor Agonist Use Does Not Impact Spine Surgery Outcomes: A Systematic Review and Meta-Analysis
Top Cited Papers
Open Access
- 3 January 2026
- journal article
- review article
- Published by SAGE Publications in Global Spine Journal
- Vol. 16 (5) , 2468-2477
Abstract
Study Design: Systematic Review and Meta-Analysis. Objectives: Despite a surge in the use of Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in spine surgery candidates, evidence on their perioperative use remains unclear. This meta-analysis aimed to synthesize the evidence on the safety and efficacy of GLP-1 RA use in patients undergoing spine surgeries. Methods: A systematic search of PubMed (MEDLINE), Embase, Scopus, ClinicalTrials.gov, and the Cochrane Central Register of Controlled Trials (CENTRAL) was conducted. Studies that compared spine surgery outcomes in GLP-1 RA users and non-users were included. Two reviewers independently selected articles. (PROSPERO: CRD420251061447). Results: Eleven retrospective studies reporting on 27,143 patients were included. Three studies focused on the cervical spine, 6 on the lumbar spine, and 2 included all spinal fusions. Risk of bias was deemed to be low in all studies. There were no significant differences in the GLP-1 RA users and non-users in pooled estimates for pseudoarthrosis (odds ratio: 1.29 [95% CI: 0.09 - 19.23]), surgical site infections (0.97 [0.74 - 1.27]), pneumonia (1.19 [0.30 - 4.68]), deep vein thrombosis (1.34 [0.86 - 2.08]), acute kidney injury (1.27 [0.93 - 1.74]), readmission rate (1.06 [0.94 - 1.18]), and emergency department visits (0.95 [0.10 - 8.99]). Conclusions: Currently available level 4 evidence suggests that perioperative GLP-1 RA use in spine surgery candidates does not affect the risk of postoperative complications. However, these studies are based on administrative databases and may be confounded by indication. Future studies should include glycemic control and weight loss to better elucidate the impact of GLP-1 RA.Keywords
This publication has 34 references indexed in Scilit:
- Trends in glucagon-like peptide 1 receptor agonist use, 2014 to 2022Journal of the American Pharmacists Association, 2023
- Anesthesia and glucagon-like peptide-1 receptor agonists: proceed with caution!Canadian Journal of Anesthesia/Journal canadien d'anesthésie, 2023
- The Effect of Diabetes and Metabolic Syndrome on Spine Surgery OutcomesCurrent Reviews in Musculoskeletal Medicine, 2022
- Fixed-Effect vs Random-Effects Models for Meta-Analysis: 3 Points to ConsiderGlobal Spine Journal, 2022
- GLP-1 receptor agonists and renal outcomes in patients with diabetes mellitus type 2 and diabetic kidney disease: state of the artClinical Kidney Journal, 2022
- The Impact of Glucagon-Like Peptide 1 Receptor Agonists on Bone Metabolism and Its Possible Mechanisms in Osteoporosis TreatmentFrontiers in Pharmacology, 2021
- The PRISMA 2020 statement: an updated guideline for reporting systematic reviewsBMJ, 2021
- Assessing underlying bone quality in spine surgery patients: a narrative review of dual-energy X-ray absorptiometry (DXA) and alternativesThe Spine Journal, 2021
- Adverse Effects of GLP-1 Receptor AgonistsThe Review of Diabetic Studies, 2014
- Complications in spine surgeryJournal of Neurosurgery: Spine, 2010